Name | 4-bromo-2-methyl-3-nitropyridine |
---|---|
Synonyms | 4-bromo-2-methyl-3-nitro-pyridine |
Density | 1.709±0.06 g/cm3(Predicted) |
---|---|
Boiling Point | 240.8±35.0 °C(Predicted) |
Molecular Formula | C6H5BrN2O2 |
Molecular Weight | 217.02000 |
Exact Mass | 215.95300 |
PSA | 58.71000 |
LogP | 2.58390 |
Hazard Codes | Xn |
---|---|
HS Code | 2933399090 |
~51% 23056-49-7 |
Literature: TAKEDA PHARMACEUTICAL COMPANY LIMITED; KWOK, Lily; LARSON, John David; SABAT, Mark Patent: WO2011/146287 A1, 2011 ; Location in patent: Page/Page column 60 ; WO 2011/146287 A1 |
~% 23056-49-7 |
Literature: TAKEDA PHARMACEUTICAL COMPANY LIMITED; KWOK, Lily; LARSON, John David; SABAT, Mark Patent: WO2011/146287 A1, 2011 ; WO 2011/146287 A1 |
~% 23056-49-7 |
Literature: TAKEDA PHARMACEUTICAL COMPANY LIMITED; KWOK, Lily; LARSON, John David; SABAT, Mark Patent: WO2011/146287 A1, 2011 ; WO 2011/146287 A1 |
Precursor 3 | |
---|---|
DownStream 1 | |
HS Code | 2933399090 |
---|---|
Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |